newsfilter
← Latest News
GlobeNewswire·

AIM ImmunoTech Announces Commencement of Rights Offering

OCALA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) – AIM ImmunoTech Inc. ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of its lead product,